{ "ok": true, "cik": "70318", "ticker": "THC", "name": "TENET HEALTHCARE CORP", "filings": [ { "form": "8-K", "filed": "2026-09-08", "items": [ "7.01 Regulation FD Disclosure", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/70318/000007031826000040/0000070318-26-000040-index.htm" }, { "form": "10-Q", "filed": "2026-07-29", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/70318/000007031826000037/0000070318-26-000037-index.htm" }, { "form": "8-K", "filed": "2026-07-23", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/70318/000007031826000032/0000070318-26-000032-index.htm" }, { "form": "8-K", "filed": "2026-05-29", "items": [ "5.07 Submission of Matters to a Vote of Security Holders" ], "url": "https://www.sec.gov/Archives/edgar/data/70318/000007031826000028/0000070318-26-000028-index.htm" }, { "form": "10-Q", "filed": "2026-04-30", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/70318/000007031826000026/0000070318-26-000026-index.htm" }, { "form": "8-K", "filed": "2026-04-30", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/70318/000007031826000023/0000070318-26-000023-index.htm" } ], "events12m": 13, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000070318.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=70318" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up TENET HEALTHCARE CORP ($THC). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-09-08. 13 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 21310000000, "revenueGrowth1y": 0.03071342200725513, "revenueGrowthPerYear": 0.022635252867393207, "yearsOfData": 5, "operatingMargin": 0.1646175504458001, "operatingMarginPrior": 0.28807738814993955, "netMargin": 0.11107461285781323, "operatingCashFlow": 3540000000, "capitalSpending": 1010000000, "freeCashFlow": 2530000000, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 2883000000, "longTermDebt": 13265000000, "longTermDebtChange": -0.00015074998115627292, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 19485000000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 19174000000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 20564000000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 20675000000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 21310000000 } ], "totalEquity": 4220000000, "totalAssets": 29677000000, "equityRatio": 0.14219766148869495, "returnOnEquity": 0.5609004739336493, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 17403868831.797993, "high": 24974023316.0745, "baseline": 22019064817.55819, "n": 1471, "band": "b10" }, "ifPaceHeld": { "low": 17403868831.797993, "high": 24974023316.0745 } }, "edgarette": "🔖 Exposure: revenue $21.3B (FY2025), total debt $13.3B. Experience: revenue up 3.1% on the year, up 2.3% a year over 4 years; operating margin 16.5%, down from 28.8%. Soundness: equity 14.2% of assets, return on equity 56.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $17.4B and $25.0B next year (method v3, set from 1,471 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (54 filers, $50M+ revenue, its industry group): operating margin 16.5% against a 2.0% median; growth 3.1% against 13.0%.", "peers": { "sic": 8062, "sicDescription": "Services-General Medical & Surgical Hospitals, NEC", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "summary": "Tenet Healthcare (THC) grew revenue 3.1% in FY2025 to $21.3 billion, operating margin 16.5% against a 2.0% median for services-general medical & surgical hospitals, nec, equity 14.2% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
TENET HEALTHCARE CORP against its own record and its peers
Operating marginPeer median 2.0%16.5%Revenue, on the yearPeer median 13.0%3.1%Equity of assetsPeer median 44.2%14.2%Return on equityPeer median 1.6%56.1%Gold tick: the median of 49–59 peers with $50M+ revenue in services-general medical & surgical hospitals, nec
", "chartHorizon": null, "backtest": { "tests": 6, "hits": 5, "rate": 0.8333333333333334, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:20:35.224Z", "hash": "6bbb5689eb3b309d", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Tenet Healthcare (THC) grew revenue 3.1% in FY2025 to $21.3 billion, operating margin 16.5% against a 2.0% median for services-general medical & surgical hospitals, nec, equity 14.2% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 21310000000, "totalDebt": 13265000000, "cash": 2883000000 }, "experience": { "revenueGrowth1y": 0.03071342200725513, "revenueGrowthPerYear": 0.022635252867393207, "operatingMargin": 0.1646175504458001, "operatingMarginPrior": 0.28807738814993955, "netMargin": 0.11107461285781323, "freeCashFlow": 2530000000 }, "soundness": { "equityRatio": 0.14219766148869495, "returnOnEquity": 0.5609004739336493, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 8062, "sicDescription": "Services-General Medical & Surgical Hospitals, NEC", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 17403868831.797993, "high": 24974023316.0745, "baseline": 22019064817.55819, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 1471, "sizeBand": "b10" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 6, "hits": 5, "rate": 0.8333333333333334, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:20:35.224Z", "hash": "6bbb5689eb3b309d", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000070318.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=70318" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }